Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, T-Cell, Cutaneous × Hematopoietic Stem Cell Transplantation × 1 year × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 11 Myelodysplastic Syndromes 9 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Leukemia, Myelomonocytic, Chronic 5 Lymphoma, Non-Hodgkin 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Hodgkin Disease 3 Graft vs Host Disease 3 Primary Myelofibrosis 2 Neoplasms, Plasma Cell 2 Multiple Myeloma 2 Lymphoma, Follicular 2 Lymphoma, B-Cell, Marginal Zone 2 Lymphoma 2 Leukemia, Biphenotypic, Acute 2 Leukemia 2 Hematologic Neoplasms 2 Anemia, Refractory, with Excess of Blasts 2 Anemia, Aplastic 2 Thrombocythemia, Essential 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Non-Malignant Neoplasm 1 Myeloproliferative Disorders 1 Motor Activity 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Leukemia, Prolymphocytic 1 Leukemia, Plasma Cell 1

Interventions

Cyclophosphamide 7 Biopsy 6 romidepsin 5 mogamulizumab 5 fludarabine 5 Brentuximab Vedotin 5 pembrolizumab 4 fludarabine phosphate 4 Specimen Handling 4 Magnetic Resonance Spectroscopy 4 Immunoglobulin G 4 Disulfides 4 ruxolitinib 3 Peripheral Blood Stem Cell Transplantation 3 Nivolumab 3 Mycophenolic Acid 3 Lenalidomide 3 Depsipeptides 3 hypericin 2 belinostat 2 Whole-Body Irradiation 2 Tacrolimus 2 Melphalan 2 Lactones 2 Etoposide 2 Busulfan 2 Bexarotene 2 trastuzumab biosimilar HLX02 1 tofacitinib 1 thymoglobulin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡